DUBLIN–(BUSINESS WIRE)–The “Clinical Chemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering.
The publisher’s Medical Devices sector report provides comprehensive information about the Clinical Chemistry Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Clinical chemistry rapid tests provide the test results immediately. These tests are used in low resource settings with the help of test strips, tablets and solutions. Clinical chemistry PoC diagnostics are used to determine the concentration or activity of blood gas, electrolytes, metabolites, enzymes, carbohydrates, proteins, lipids and small molecules.
Scope
Extensive coverage of the Clinical Chemistry Rapid Tests & POC under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Clinical Chemistry Rapid Tests & POC and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Clinical Chemistry Rapid Tests & POC under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Key Topics Covered:
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Clinical Chemistry Rapid Tests & POC Overview
3 Products under Development
3.1 Clinical Chemistry Rapid Tests & POC – Pipeline Products by Stage of Development
3.2 Clinical Chemistry Rapid Tests & POC – Pipeline Products by Territory
3.3 Clinical Chemistry Rapid Tests & POC – Pipeline Products by Regulatory Path
3.4 Clinical Chemistry Rapid Tests & POC – Pipeline Products by Estimated Approval Date
3.5 Clinical Chemistry Rapid Tests & POC – Ongoing Clinical Trials
4 Clinical Chemistry Rapid Tests & POC – Pipeline Products under Development by Companies
4.1 Clinical Chemistry Rapid Tests & POC Companies – Pipeline Products by Stage of Development
4.2 Clinical Chemistry Rapid Tests & POC – Pipeline Products by Stage of Development
5 Clinical Chemistry Rapid Tests & POC Companies and Product Overview
6 Clinical Chemistry Rapid Tests & POC- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
Companies Mentioned
Abreos Biosciences Inc
Acetaminophen Toxicity Diagnostics, LLC
Affinergy LLC
Am Biotechnologies, LLC
AnaZyme LLC
Angle Biosciences Inc
Augurix SA
Baebies Inc
Base Pair Biotechnologies Inc
Biocross SL
Bioftalmik Applied Research
Biotech Resources Aust Pty Ltd
Boditech Med Inc
Burnet Institute
Calmark Sweden AB
Cambridge Diagnostic Imaging Ltd
Carclo Diagnostic Solutions Ltd
CardioGenics Inc
Cellex Inc
Center for Biomedical Research Network in Bioengineering, Biomaterials and Nanomedicine
Claremont BioSolutions
Columbia University
DiaSys Diagnostic Systems GmbH
Edan Instruments Inc
Foundation for Innovative New Diagnostics
GlucoSentient Inc
Group K Diagnostics
Instrumentation Laboratory Co
IPI Singapore
IR2Dx Inc.
Magee-Womens Research Institute
Massachusetts Institute of Technology
Medical University of South Carolina
MiCo BioMed Co Ltd
Monash University
Montana State University
NanoSpeed Diagnostics Inc
Ohmx Corp
OPKO Health Inc
Oxford Immunotec Ltd
Pennsylvania State University
PortaScience Inc
ProciseDx LLC
Quidel Corp
SaltCheck Inc (Inactive)
Seattle Children’s Hospital
SenGenix Inc
Systagenix Wound Management Ltd
The University of New South Wales press Limited
Thermo Fisher Scientific Inc
Universal Biosensors Inc
University of Edinburgh
University of Florida
University of South Australia
UrSure Inc
For more information about this report visit https://www.researchandmarkets.com/r/16fyh8
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
